"While I don’t like it , it’s probably prudent mgmt to do so as you never know when it comes to trial results" Prudent for them, as they keep their jobs if it's a fail. But then those who took part in the cap raising are sitting on a big loss.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025